2025 annual financial data

Aclaris Therapeutics 2025 Net margin

Direct answer

Net margin was -829.58%.

Operating income was -76,375,000 USD and net income was -64,923,000 USD.
Operating cash flow was -47,113,000 USD.

Get free Aclaris Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,826,000 USD
Operating income
-76,375,000 USD
Net income
-64,923,000 USD
Operating cash flow
-47,113,000 USD